Evaluation of the thrombogenecity of microvascular prosthesis by in vivo microscopy.
Expanded polytetrafluoroethylene(ePTFE) grafts 4mm long and 1mm in diameter were implanted into the iliac artery of 100-150g male rats using standard microvascular technique. Prior to clamp removal, the cremaster muscle was isolated as an island flap based on the iliac artery and observed using intravital fluorescence microscopy. Fields which contained a bifurcation of a first order arteriole(80-100 microns diameter) into second order arteriole(50-80 microns) were chosen for observation. Platelets were labeled in vivo with acridine red to visualize and quantify the aggregates. Images of microemboli were counted manually and the area was measured by computerized planimetry. Six control grafts were implanted with no further processing, six were irrigated with heparin, and six were coated with tridodecylmethylammonium chloride(TDMAC) and heparin. Most thrombi appeared within the first five minutes after implantation in all groups. The total number of emboli observed in the control group was 91 pr animal, in the heparin irrigation group it was 84, and in the TDMAC-heparin group it was 22. The total thrombus area observed per animal was 137,660 +/- 29,467 microns 2 in the control group, 79,040 +/- 10,893 microns 2 in the heparin irrigation group, and 17,498 +/- 6,059 microns 2 in the TDMAC-heparin group (p < .01 vs control or heparin irrigation group). With this results we could find that heparin irrigation and TDMAC-heparin coating appear to reduce the number, size, and total amount of microemboli generated by ePTFE graft implantation and apparent thromboresistant property of TDMAC-heparin coating may have widespread application in many clinical and research areas and this experimental model can be used for evaluation of other graft matrials.
Kim
Y B
YB
Department of Plastic and Reconstructive Surgery, College of Medicine Soonchunhyang University, Yongsan-gu, Seoul, Korea.
Reisch
H P
HP
Serafin
D
D
Klitzman
B
B
D000818:Animals; D001807:Blood Vessel Prosthesis / Q000009:adverse effects*; D006493:Heparin / Q000494:pharmacology; D008297:Male; D008833:Microcirculation / Q000601:surgery; D011138:Polytetrafluoroethylene / Q000009:adverse effects; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D051381:Rats; D013927:Thrombosis / Q000209:etiology* / Q000517:prevention & control
D000644:Quaternary Ammonium Compounds; C009543:tridodecylmethylammonium; D011138:Polytetrafluoroethylene; D006493:Heparin